Home  >  Health Check  >  Covid-19 plasma therapy trial results ‘disappointing’
Health Check
Covid-19 plasma therapy trial results ‘disappointing’
Health Check
Oct 28, 2020

For months now, many people hospitalised with Covid-19 have been given convalescent plasma – donated blood serum from people who’ve already had the illness. The hope has been that transfusing donated antibodies against the coronavirus will help to prevent deaths and serious illness. Convalescent plasma therapy received a high profile boost in the USA in August when the Trump administration announced emergency use authorisation for the treatment, despite the lack of robust evidence for its efficacy against the coronavirus. Now the results of the first completed randomised clinical trial of the therapy have been published in the British Medical Journal. The findings are not particularly encouraging. In this Indian study, there was no difference in the death rate or the progression from moderate to severe disease between patients given the therapy and those receiving only standard care. Claudia Hammond talks to Dr Aparna Mukherjee of the India Council of Medical Research and the BBC’s medicine and science correspondent James Gallagher about the prospects now for convalescent plasma therapy.

Health Check also asks whether vaccines against other diseases might provide some protection against the coronavirus, and features a report from California where a lot of mental health counselling has gone online or on the phone since the pandemic took hold. Reporter Alison Van Diggelen asks people with mental health problems and their therapists how they feel about the loss of face-to-face sessions.

Presenter: Claudia Hammond Producer: Andrew Luck-Baker

(Picture: An Iraqi phlebotomist holds a bag of plasma donated by a recovered Covid-19 patient. Photo credit: Asaad Niazi/AFP/Getty Images.)

More Episodes


Mar 25, 2026
Antimicrobial resistance in conflict zones

For the last few weeks, the news has been dominated by the situation in the Middle East. Joining Claudia Hammond is BBC Health Correspondent James Gallagher who speaks with Dr Antoine Abou Fayad, a microbiologist and medicinal chemist based in Beirut, Lebanon. He reveals that war, just like the ongoing conflict in the Middle East, provides the perfect storm to accelerate the spread of multidrug-resistant infections. And nobody is safe.

Following the recent meningitis B outbreak in the UK which has killed two people and led to the rollout of vaccines and preventative antibiotics, Claudia and James discuss how meningitis outbreaks are dealt with in the ‘meningitis belt’ - an area stretching across 26 sub-Saharan African countries and talk about a new vaccine aiming to stop deadly meningitis epidemics which has been confirmed to be safe following analysis of vaccination campaigns in Nigeria and Niger.

And India's snakebite crisis is killing near sixty thousand people every year, about six people every hour. Journalist Chhavi Sachdev joins us to discuss the progress of India’s National Action Plan to tackle snakebite envenoming which launched two years ago. Also, what time of day do you exercise? Well, a new study using Fitbit-derived heart rate data has found that people who regularly exercised early in the morning were significantly less likely to have coronary artery disease, high blood pressure, Type 2 diabetes or obesity compared with people who exercised later in the day.

Presenter: Claudia Hammond Producer: Jonathan Blackwell


26min 28sec

Mar 18, 2026
Does your home country impact your cancer risk?

North Korean defectors and lifelong South Korean residents have significantly different cancer rates, despite their genetic similarities; new research finds. Presenter Laura Foster unpacks this study, explaining what it tells us about how upbringing and environment contribute to different cancer rates, and how migration can change these risks.

A new study has found GLP-1s – drugs typically used to treat diabetes and obesity – could have an unexpected benefit for patients dealing with substance abuse disorders. Laura speaks with Ziyad Al-Aly, a clinical epidemiologist and Veterans Affairs physician at Washington University in St Louis to understand what this could mean for treating drug and alcohol addictions, and what questions still need answers before this treatment can be rolled out.

Last weekend, Kenya’s National Environment Management Authority rolled out new waste management rules to better dispose of products containing plastic, but the new laws are expected to increase the price of sanitary pads by 20%. Global health reporter based in Nairobi, Dorcas Wangira joins Laura to unpack what these policies mean for the accessibility of sanitary products, and what alternative solutions are needed to balance access with environmental impact. They also discuss how a drug to treat Parkinson’s disease can be made from waste plastic bottles using a pioneering method.

And Jane Chambers reports from Peru about the growing prevalence of anaemia, speaking to local healthcare workers about what steps families can be taken to help their children recover.

Presenter: Laura Foster Producers: Jonathan Blackwell and Georgia Christie


26min 28sec

Covid-19 plasma therapy trial results ‘disappointing’

--:--
--:--